These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10378725)
41. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al. Raghu P; Grover PS; Kumar A Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338 [No Abstract] [Full Text] [Related]
47. Side effects and management of side effects of methotrexate in rheumatoid arthritis. Albrecht K; Müller-Ladner U Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S95-101. PubMed ID: 21044440 [TBL] [Abstract][Full Text] [Related]
48. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis. Calvo-Romero JM Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624 [TBL] [Abstract][Full Text] [Related]
49. Severe myelotoxicity in rheumatoid arthritis patients treated with oral methotrexate. Rodriguez-Gomez M; Fernandez-Sueiro JL; Ulibarrena C; Lopez-Barros G; Willisch A; Fernandez-Dominguez L Clin Exp Rheumatol; 2001; 19(3):353. PubMed ID: 11407096 [No Abstract] [Full Text] [Related]
50. Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis. Sánchez G; Castro JS; Snih SA; Blanco LP; Esteva MH; Macgregor EG; González M; Granados Y; Marín F; Rosas A; Tristano A; Chirinos E; Mundaraín L; Sanoja G; Zambrano-Marín G; Rodríguez MA Rheumatol Int; 2007 Apr; 27(6):531-6. PubMed ID: 17102944 [TBL] [Abstract][Full Text] [Related]
51. Strength of methotrexate tablets. Vecchio P Rheumatology (Oxford); 2000 Sep; 39(9):1047. PubMed ID: 10986317 [No Abstract] [Full Text] [Related]
52. [Methotrexate]. Rau R Z Rheumatol; 2016 Aug; 75(6):599-603. PubMed ID: 27365027 [No Abstract] [Full Text] [Related]
53. Remission of a primary thyroid lymphoma after methotrexate withdrawal. de Mast Q; Haverman J; Netten PM; Sinnige HA Clin Endocrinol (Oxf); 2006 Jun; 64(6):716-7. PubMed ID: 16712679 [No Abstract] [Full Text] [Related]
54. Cytotoxic chemotherapy administration in the community: A case study. Ridings S; Doherty T; Smith A; Morris B; Cameron K Aust Nurs Midwifery J; 2015 Dec; 23(6):28. PubMed ID: 26863712 [No Abstract] [Full Text] [Related]
55. Tofacitinib versus methotrexate in rheumatoid arthritis. Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF; N Engl J Med; 2014 Jun; 370(25):2377-86. PubMed ID: 24941177 [TBL] [Abstract][Full Text] [Related]
56. Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis. Lyon CC; Thompson D J Rheumatol; 1997 Mar; 24(3):589-91. PubMed ID: 9058671 [TBL] [Abstract][Full Text] [Related]
58. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011? Singer O; Gibofsky A Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570 [TBL] [Abstract][Full Text] [Related]
59. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. van der Veen MJ; Dekker JJ; Dinant HJ; van Soesbergen RM; Bijlsma JW J Rheumatol; 1995 Sep; 22(9):1766-8. PubMed ID: 8523359 [TBL] [Abstract][Full Text] [Related]